New Pfizer/BioNTech COVID-19 Vaccine Data Confirm Prior Results, Show T-Cell Boost

 
• By Mandy Jackson
Vaccination against the new Corona Virus SARS-CoV-2: A syringe being drawn up with SARS-CoV-2 vaccination.
Pfizer and BioNTech report results from a second Phase I/II study, which was conducted in Germany • Source: Shutterstock

More from COVID-19

More from Scrip